Gene Symbol | Gene ID | Gene Info |
---|---|---|
Vdr
|
ENSMUSG00000022479.9 | vitamin D (1,25-dihydroxyvitamin D3) receptor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_97879087_97879238 | Vdr | 17651 | 0.161709 | 0.51 | 7.6e-05 | Click! |
chr15_97907777_97908138 | Vdr | 353 | 0.873672 | 0.50 | 1.1e-04 | Click! |
chr15_97908566_97908738 | Vdr | 342 | 0.879190 | 0.46 | 4.6e-04 | Click! |
chr15_97908180_97908506 | Vdr | 33 | 0.976723 | 0.43 | 1.2e-03 | Click! |
chr15_97865247_97865455 | Vdr | 5653 | 0.186031 | 0.39 | 3.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_20518100_20518462 | 21.45 |
Gm17229 |
predicted gene 17229 |
117 |
0.97 |
chr14_14351950_14353283 | 16.28 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr10_20518494_20518668 | 12.58 |
Gm17229 |
predicted gene 17229 |
417 |
0.87 |
chr7_74182613_74183104 | 11.81 |
Gm27459 |
predicted gene, 27459 |
52700 |
0.15 |
chr4_11147788_11148157 | 11.11 |
Gm11830 |
predicted gene 11830 |
3262 |
0.15 |
chr10_127508848_127510720 | 10.76 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr4_154025644_154026533 | 10.41 |
Smim1 |
small integral membrane protein 1 |
51 |
0.95 |
chr11_116549279_116549557 | 10.24 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
577 |
0.49 |
chr1_185502579_185502891 | 9.92 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
5347 |
0.19 |
chr2_121036499_121036885 | 9.85 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr1_184656869_184657047 | 9.62 |
Gm37800 |
predicted gene, 37800 |
27485 |
0.12 |
chr5_139388991_139389572 | 9.40 |
Gpr146 |
G protein-coupled receptor 146 |
504 |
0.68 |
chr14_79300760_79302137 | 9.09 |
Rgcc |
regulator of cell cycle |
197 |
0.94 |
chr17_29500727_29501066 | 8.92 |
Pim1 |
proviral integration site 1 |
7489 |
0.11 |
chr7_142574309_142575453 | 8.75 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr6_124919273_124920636 | 8.69 |
Ptms |
parathymosin |
149 |
0.88 |
chr3_144198270_144199266 | 8.58 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr5_130200680_130200989 | 8.41 |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
6219 |
0.1 |
chr8_83600341_83600635 | 8.40 |
Gm18001 |
predicted gene, 18001 |
475 |
0.65 |
chr12_80084359_80084746 | 8.34 |
Gm36660 |
predicted gene, 36660 |
3118 |
0.18 |
chr2_170459761_170460089 | 8.25 |
Gm14269 |
predicted gene 14269 |
3894 |
0.19 |
chr7_127672339_127672529 | 8.21 |
Gm44760 |
predicted gene 44760 |
14200 |
0.08 |
chr3_94782994_94783366 | 7.96 |
Cgn |
cingulin |
3271 |
0.16 |
chr4_154929190_154929525 | 7.93 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr11_78070046_78070228 | 7.80 |
Mir144 |
microRNA 144 |
2868 |
0.11 |
chr5_142519953_142520104 | 7.75 |
Papolb |
poly (A) polymerase beta (testis specific) |
10048 |
0.15 |
chr1_23187529_23187699 | 7.44 |
Gm29506 |
predicted gene 29506 |
48059 |
0.11 |
chr1_84851830_84852040 | 7.44 |
Trip12 |
thyroid hormone receptor interactor 12 |
11419 |
0.14 |
chr9_58657759_58658148 | 7.42 |
Rec114 |
REC114 meiotic recombination protein |
1339 |
0.42 |
chr2_69897352_69898558 | 7.32 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
652 |
0.6 |
chr8_122317511_122318419 | 7.28 |
Zfpm1 |
zinc finger protein, multitype 1 |
10645 |
0.13 |
chr12_88984393_88984775 | 7.26 |
Nrxn3 |
neurexin III |
31185 |
0.23 |
chr5_137786077_137787112 | 7.25 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr7_125632212_125632595 | 7.19 |
Gtf3c1 |
general transcription factor III C 1 |
17574 |
0.17 |
chr19_24794396_24794754 | 7.17 |
Pgm5 |
phosphoglucomutase 5 |
31497 |
0.16 |
chr15_98608664_98610204 | 7.14 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chrX_10714525_10715126 | 7.09 |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
188 |
0.93 |
chr11_102348366_102348578 | 7.06 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
12096 |
0.1 |
chr13_95679133_95679359 | 7.02 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
3078 |
0.18 |
chr11_87368253_87368600 | 6.98 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr9_70927189_70927340 | 6.96 |
Gm32017 |
predicted gene, 32017 |
3224 |
0.26 |
chr7_142570403_142571198 | 6.94 |
H19 |
H19, imprinted maternally expressed transcript |
5738 |
0.11 |
chr9_65070584_65070992 | 6.93 |
Dpp8 |
dipeptidylpeptidase 8 |
4215 |
0.17 |
chr3_89133494_89133818 | 6.89 |
Pklr |
pyruvate kinase liver and red blood cell |
2486 |
0.11 |
chr14_75837044_75838069 | 6.89 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr5_123181829_123181980 | 6.83 |
Hpd |
4-hydroxyphenylpyruvic acid dioxygenase |
163 |
0.9 |
chr5_147441974_147442285 | 6.70 |
Gm42883 |
predicted gene 42883 |
2739 |
0.14 |
chr17_29447307_29447534 | 6.69 |
Gm36199 |
predicted gene, 36199 |
1515 |
0.27 |
chr2_24351152_24351450 | 6.63 |
Il1rn |
interleukin 1 receptor antagonist |
5953 |
0.15 |
chr11_90676147_90676490 | 6.61 |
Tom1l1 |
target of myb1-like 1 (chicken) |
11261 |
0.2 |
chr19_24517179_24517341 | 6.59 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
38529 |
0.14 |
chr16_96906661_96906967 | 6.58 |
Gm32432 |
predicted gene, 32432 |
11918 |
0.3 |
chr11_102353202_102353451 | 6.55 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
7242 |
0.11 |
chr15_76688946_76689125 | 6.50 |
Ppp1r16a |
protein phosphatase 1, regulatory subunit 16A |
146 |
0.88 |
chr14_116946057_116946269 | 6.49 |
Gpc6 |
glypican 6 |
20227 |
0.3 |
chr16_4012853_4013176 | 6.48 |
Slx4 |
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) |
9244 |
0.1 |
chr18_63203873_63204037 | 6.39 |
Gm50171 |
predicted gene, 50171 |
35483 |
0.17 |
chr11_11815614_11815785 | 6.36 |
Fignl1 |
fidgetin-like 1 |
6737 |
0.19 |
chr9_43263943_43264179 | 6.34 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
72 |
0.97 |
chr10_62327543_62328005 | 6.31 |
Hk1 |
hexokinase 1 |
7 |
0.97 |
chr9_63201505_63201702 | 6.30 |
Skor1 |
SKI family transcriptional corepressor 1 |
52642 |
0.12 |
chr11_32283952_32284215 | 6.27 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
272 |
0.83 |
chr1_86501052_86501969 | 6.26 |
Ptma |
prothymosin alpha |
25216 |
0.11 |
chr9_66212903_66213068 | 6.25 |
Dapk2 |
death-associated protein kinase 2 |
7762 |
0.23 |
chr1_86527639_86529135 | 6.13 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr11_116074538_116074690 | 6.05 |
Unc13d |
unc-13 homolog D |
2437 |
0.15 |
chr18_70563066_70563368 | 6.02 |
Mbd2 |
methyl-CpG binding domain protein 2 |
4972 |
0.2 |
chr10_127879046_127879363 | 6.00 |
Rdh7 |
retinol dehydrogenase 7 |
9126 |
0.09 |
chr9_107589865_107590397 | 5.90 |
Ifrd2 |
interferon-related developmental regulator 2 |
305 |
0.66 |
chr18_50028238_50028565 | 5.83 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr2_28622618_28622798 | 5.78 |
Gfi1b |
growth factor independent 1B |
726 |
0.52 |
chr2_153492229_153493481 | 5.75 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr11_58588191_58588366 | 5.74 |
Olfr324 |
olfactory receptor 324 |
6836 |
0.07 |
chrX_20950586_20951120 | 5.74 |
Elk1 |
ELK1, member of ETS oncogene family |
245 |
0.87 |
chr5_37457926_37458192 | 5.70 |
Evc2 |
EvC ciliary complex subunit 2 |
42200 |
0.16 |
chr16_93166741_93167038 | 5.69 |
Gm28003 |
predicted gene, 28003 |
94134 |
0.08 |
chr4_136214938_136215135 | 5.69 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
8671 |
0.14 |
chr16_4559726_4560765 | 5.69 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr11_87749523_87749886 | 5.67 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr1_181249627_181249802 | 5.67 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
7394 |
0.15 |
chr12_110978382_110979023 | 5.67 |
Ankrd9 |
ankyrin repeat domain 9 |
84 |
0.95 |
chr2_166116203_166116481 | 5.67 |
Sulf2 |
sulfatase 2 |
38081 |
0.13 |
chr1_185515526_185516243 | 5.62 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18496 |
0.17 |
chr15_96075644_96075923 | 5.61 |
D030018L15Rik |
RIKEN cDNA D030018L15 gene |
2351 |
0.38 |
chr7_127121968_127122143 | 5.61 |
Qprt |
quinolinate phosphoribosyltransferase |
14 |
0.94 |
chr17_48272064_48272554 | 5.58 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr14_76817069_76817629 | 5.57 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr1_161894176_161894553 | 5.57 |
Gm31925 |
predicted gene, 31925 |
2217 |
0.25 |
chr11_78408869_78409132 | 5.56 |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
13217 |
0.09 |
chr6_127322214_127322412 | 5.56 |
Gm42458 |
predicted gene 42458 |
3544 |
0.15 |
chr9_114815468_114815650 | 5.53 |
Gm23889 |
predicted gene, 23889 |
22614 |
0.13 |
chr6_67149473_67149848 | 5.51 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
15264 |
0.15 |
chr17_28288085_28288332 | 5.51 |
Ppard |
peroxisome proliferator activator receptor delta |
5038 |
0.12 |
chr2_32116110_32116272 | 5.49 |
Plpp7 |
phospholipid phosphatase 7 (inactive) |
20036 |
0.1 |
chr11_95805814_95806002 | 5.48 |
Phospho1 |
phosphatase, orphan 1 |
18591 |
0.1 |
chr16_93744903_93745196 | 5.45 |
Dop1b |
DOP1 leucine zipper like protein B |
14950 |
0.16 |
chr2_146099017_146099372 | 5.45 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr2_141286003_141286163 | 5.44 |
Macrod2os1 |
mono-ADP ribosylhydrolase 2, opposite strand 1 |
908 |
0.7 |
chr11_75462325_75462847 | 5.42 |
Tlcd2 |
TLC domain containing 2 |
871 |
0.25 |
chr2_143871286_143871677 | 5.41 |
Gm11673 |
predicted gene 11673 |
6468 |
0.14 |
chr3_31079635_31079799 | 5.41 |
Skil |
SKI-like |
15341 |
0.17 |
chr11_72475297_72475734 | 5.40 |
Spns2 |
spinster homolog 2 |
488 |
0.74 |
chr9_106821518_106822739 | 5.38 |
Dcaf1 |
DDB1 and CUL4 associated factor 1 |
254 |
0.89 |
chr3_94693946_94694097 | 5.36 |
Selenbp2 |
selenium binding protein 2 |
362 |
0.78 |
chr19_53256802_53257001 | 5.35 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
1681 |
0.31 |
chr9_104161119_104161282 | 5.34 |
Dnajc13 |
DnaJ heat shock protein family (Hsp40) member C13 |
591 |
0.66 |
chrX_142680720_142682167 | 5.30 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr5_22347938_22348111 | 5.29 |
Reln |
reelin |
3322 |
0.18 |
chr3_104671656_104671921 | 5.27 |
Gm29560 |
predicted gene 29560 |
1778 |
0.2 |
chr4_154024422_154024962 | 5.25 |
Smim1 |
small integral membrane protein 1 |
337 |
0.78 |
chr8_123978851_123979300 | 5.25 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4047 |
0.12 |
chr9_45188673_45188860 | 5.23 |
BC049352 |
cDNA sequence BC049352 |
6732 |
0.1 |
chr6_113690907_113691133 | 5.23 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
275 |
0.73 |
chr3_84479376_84481034 | 5.22 |
Fhdc1 |
FH2 domain containing 1 |
188 |
0.96 |
chr10_81627030_81627544 | 5.22 |
Sirt6 |
sirtuin 6 |
30 |
0.93 |
chr19_10658108_10658425 | 5.21 |
Vwce |
von Willebrand factor C and EGF domains |
277 |
0.82 |
chr7_25390031_25390717 | 5.21 |
Lipe |
lipase, hormone sensitive |
103 |
0.93 |
chr16_23294359_23294543 | 5.21 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
3981 |
0.21 |
chr2_167696163_167696452 | 5.21 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
5126 |
0.12 |
chr12_84206523_84206832 | 5.20 |
Gm47447 |
predicted gene, 47447 |
9460 |
0.11 |
chr19_6969291_6970359 | 5.19 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr17_47694297_47695658 | 5.19 |
Frs3 |
fibroblast growth factor receptor substrate 3 |
221 |
0.44 |
chr14_64689914_64690065 | 5.17 |
Kif13b |
kinesin family member 13B |
37387 |
0.15 |
chr5_137293156_137293696 | 5.16 |
Mir8116 |
microRNA 8116 |
354 |
0.64 |
chr11_74572712_74572939 | 5.13 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
17299 |
0.18 |
chr9_95572657_95572940 | 5.08 |
Paqr9 |
progestin and adipoQ receptor family member IX |
13141 |
0.13 |
chr10_125328429_125328841 | 5.08 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
100 |
0.98 |
chr8_71381974_71382671 | 5.08 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
362 |
0.74 |
chr2_174858311_174858924 | 5.08 |
Gm14616 |
predicted gene 14616 |
2328 |
0.26 |
chr18_73785696_73786249 | 5.08 |
Me2 |
malic enzyme 2, NAD(+)-dependent, mitochondrial |
29466 |
0.14 |
chr15_95838544_95838755 | 5.06 |
Gm17546 |
predicted gene, 17546 |
8577 |
0.15 |
chr2_70838633_70838816 | 5.05 |
Tlk1 |
tousled-like kinase 1 |
12996 |
0.18 |
chr5_28055448_28055803 | 5.04 |
Gm26608 |
predicted gene, 26608 |
166 |
0.94 |
chr5_125392632_125393301 | 5.04 |
Ubc |
ubiquitin C |
2764 |
0.16 |
chr10_128747405_128748339 | 5.03 |
Pym1 |
PYM homolog 1, exon junction complex associated factor |
17 |
0.94 |
chr19_43986061_43986390 | 5.02 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
331 |
0.86 |
chr5_139796762_139798525 | 5.00 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
129 |
0.94 |
chr2_122125721_122125915 | 5.00 |
Spg11 |
SPG11, spatacsin vesicle trafficking associated |
7432 |
0.14 |
chr19_55195685_55195854 | 4.99 |
Mir6715 |
microRNA 6715 |
3091 |
0.22 |
chr10_86636937_86637406 | 4.99 |
Gm19989 |
predicted gene, 19989 |
32 |
0.92 |
chr18_5142609_5142807 | 4.99 |
Gm26682 |
predicted gene, 26682 |
23023 |
0.21 |
chr4_139335538_139335703 | 4.95 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1560 |
0.18 |
chr6_90333135_90333323 | 4.94 |
Uroc1 |
urocanase domain containing 1 |
55 |
0.95 |
chr11_95319679_95319838 | 4.93 |
Gm11520 |
predicted gene 11520 |
9329 |
0.12 |
chr4_130714916_130715092 | 4.93 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34630 |
0.11 |
chr7_68189271_68189540 | 4.93 |
Igf1r |
insulin-like growth factor I receptor |
2780 |
0.3 |
chr7_19865312_19865592 | 4.93 |
Ceacam16 |
carcinoembryonic antigen-related cell adhesion molecule 16 |
4153 |
0.08 |
chr8_10854830_10855021 | 4.92 |
Gm32540 |
predicted gene, 32540 |
11261 |
0.12 |
chr2_30893330_30893679 | 4.92 |
Ptges |
prostaglandin E synthase |
3965 |
0.16 |
chr6_6207830_6208079 | 4.90 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
9164 |
0.24 |
chr9_69087390_69087551 | 4.90 |
Rora |
RAR-related orphan receptor alpha |
108071 |
0.07 |
chr3_14877046_14877264 | 4.90 |
Car3 |
carbonic anhydrase 3 |
7977 |
0.19 |
chr15_58140746_58142050 | 4.89 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr5_8063279_8063476 | 4.89 |
Sri |
sorcin |
2111 |
0.25 |
chr7_143305657_143306136 | 4.89 |
Gm37364 |
predicted gene, 37364 |
8198 |
0.14 |
chr11_87763473_87764852 | 4.87 |
Tspoap1 |
TSPO associated protein 1 |
569 |
0.56 |
chr18_3270627_3271079 | 4.87 |
Crem |
cAMP responsive element modulator |
10225 |
0.22 |
chr4_141545541_141546268 | 4.85 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
285 |
0.86 |
chr5_3343562_3344628 | 4.84 |
Cdk6 |
cyclin-dependent kinase 6 |
179 |
0.96 |
chr6_87873042_87873340 | 4.84 |
Copg1 |
coatomer protein complex, subunit gamma 1 |
14623 |
0.08 |
chr12_80103423_80104027 | 4.84 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr4_154881181_154881372 | 4.83 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
933 |
0.46 |
chr10_56106920_56107369 | 4.82 |
Msl3l2 |
MSL3 like 2 |
227 |
0.94 |
chr11_94468409_94469097 | 4.82 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4888 |
0.15 |
chr7_110914639_110914941 | 4.82 |
Mrvi1 |
MRV integration site 1 |
8913 |
0.17 |
chr11_74837693_74838808 | 4.81 |
Mnt |
max binding protein |
782 |
0.52 |
chrX_98961322_98961579 | 4.81 |
Gm14813 |
predicted gene 14813 |
1028 |
0.55 |
chr16_44175196_44175505 | 4.80 |
Usf3 |
upstream transcription factor family member 3 |
1953 |
0.33 |
chr10_111581962_111582113 | 4.80 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
12236 |
0.15 |
chr6_87542036_87542386 | 4.79 |
Gm44198 |
predicted gene, 44198 |
8804 |
0.15 |
chr16_38286028_38286182 | 4.79 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
8719 |
0.15 |
chr8_109579142_109579319 | 4.78 |
Hp |
haptoglobin |
58 |
0.96 |
chr5_15591695_15592053 | 4.78 |
Gm30613 |
predicted gene, 30613 |
13192 |
0.14 |
chr5_97834809_97835101 | 4.78 |
Antxr2 |
anthrax toxin receptor 2 |
161140 |
0.03 |
chr19_4859385_4859709 | 4.77 |
Ctsf |
cathepsin F |
166 |
0.88 |
chr7_28179836_28180482 | 4.77 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr3_65658208_65659857 | 4.77 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr2_3657823_3658259 | 4.77 |
Gm13183 |
predicted gene 13183 |
22549 |
0.15 |
chr2_180237013_180237184 | 4.75 |
Lama5 |
laminin, alpha 5 |
11239 |
0.11 |
chr6_120831349_120831552 | 4.75 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
4762 |
0.16 |
chrX_101299536_101300464 | 4.75 |
Nlgn3 |
neuroligin 3 |
474 |
0.66 |
chr11_87701114_87701265 | 4.74 |
1110028F11Rik |
RIKEN cDNA 1110028F11 gene |
207 |
0.86 |
chr1_87636784_87636958 | 4.73 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
15197 |
0.16 |
chr7_126271797_126273090 | 4.73 |
Sbk1 |
SH3-binding kinase 1 |
176 |
0.92 |
chr9_66154142_66154293 | 4.73 |
Dapk2 |
death-associated protein kinase 2 |
4006 |
0.21 |
chr7_24377117_24377824 | 4.73 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
4700 |
0.1 |
chr11_32296772_32297209 | 4.72 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
362 |
0.77 |
chr5_123039469_123039645 | 4.71 |
Morn3 |
MORN repeat containing 3 |
1845 |
0.17 |
chr19_20761774_20761949 | 4.70 |
Aldh1a7 |
aldehyde dehydrogenase family 1, subfamily A7 |
34299 |
0.19 |
chr4_124817853_124818126 | 4.69 |
n-R5s192 |
nuclear encoded rRNA 5S 192 |
2832 |
0.14 |
chr4_38334865_38335055 | 4.68 |
Gm12380 |
predicted gene 12380 |
71042 |
0.14 |
chr15_5459671_5459851 | 4.68 |
Gm46496 |
predicted gene, 46496 |
4414 |
0.27 |
chr6_5188940_5189281 | 4.67 |
Pon1 |
paraoxonase 1 |
4653 |
0.22 |
chr11_96945021_96945293 | 4.66 |
D030028A08Rik |
RIKEN cDNA D030028A08 gene |
845 |
0.33 |
chr13_20128234_20128402 | 4.66 |
Elmo1 |
engulfment and cell motility 1 |
16806 |
0.27 |
chr5_146018257_146018566 | 4.66 |
Gm8454 |
predicted gene 8454 |
570 |
0.66 |
chr2_93452290_93452510 | 4.65 |
Cd82 |
CD82 antigen |
279 |
0.62 |
chr9_108569718_108570862 | 4.63 |
Dalrd3 |
DALR anticodon binding domain containing 3 |
376 |
0.53 |
chr1_77298959_77299132 | 4.63 |
Epha4 |
Eph receptor A4 |
78562 |
0.11 |
chr18_4921251_4922052 | 4.63 |
Svil |
supervillin |
75 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.8 | 8.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.4 | 12.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.4 | 11.8 | GO:0070627 | ferrous iron import(GO:0070627) |
2.3 | 7.0 | GO:0040031 | snRNA modification(GO:0040031) |
2.3 | 6.9 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
2.2 | 8.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.1 | 6.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
2.1 | 6.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
2.0 | 6.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.0 | 15.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.0 | 5.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.9 | 9.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.9 | 3.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.9 | 5.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.9 | 5.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.8 | 5.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.8 | 5.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.7 | 5.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.7 | 5.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.7 | 6.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.7 | 6.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.6 | 4.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.6 | 1.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.6 | 8.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.6 | 4.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.6 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 9.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.6 | 4.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 1.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.6 | 4.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.6 | 4.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.6 | 7.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.6 | 1.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.5 | 1.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.5 | 5.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.5 | 5.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.5 | 1.5 | GO:0030910 | olfactory placode formation(GO:0030910) lens induction in camera-type eye(GO:0060235) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.4 | 7.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 1.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.4 | 1.4 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) negative regulation of histone H4 acetylation(GO:0090241) |
1.4 | 4.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.4 | 2.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.4 | 4.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.4 | 4.3 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 5.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.4 | 5.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.4 | 4.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.4 | 5.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.4 | 4.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.4 | 4.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.4 | 1.4 | GO:0070384 | Harderian gland development(GO:0070384) |
1.4 | 4.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.3 | 2.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.3 | 5.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 4.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.3 | 3.9 | GO:0000087 | mitotic M phase(GO:0000087) |
1.3 | 6.5 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.3 | 1.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.3 | 6.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.3 | 3.8 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.3 | 3.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.3 | 3.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.3 | 3.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.2 | 3.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 3.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 7.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.2 | 5.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.2 | 3.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.2 | 3.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.2 | 1.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.2 | 2.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.2 | 2.4 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.2 | 6.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.2 | 7.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.2 | 3.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.2 | 7.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.2 | 1.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.2 | 3.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.2 | 3.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.2 | 5.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.1 | 4.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.1 | 3.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 7.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.1 | 3.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.1 | 2.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
1.1 | 5.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 1.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.1 | 29.7 | GO:0048821 | erythrocyte development(GO:0048821) |
1.1 | 3.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.1 | 3.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.1 | 2.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.1 | 2.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.1 | 5.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 5.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.1 | 3.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 3.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.1 | 5.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.1 | 3.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
1.1 | 3.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 2.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.1 | 11.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.1 | 1.1 | GO:0046618 | drug export(GO:0046618) |
1.1 | 2.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.1 | 3.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.1 | 6.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.0 | 4.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.0 | 1.0 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.0 | 3.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.0 | 2.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.0 | 7.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.0 | 3.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
1.0 | 9.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.0 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 3.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.0 | 5.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 2.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
1.0 | 5.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 5.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.0 | 2.0 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
1.0 | 4.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.0 | 3.0 | GO:0008050 | female courtship behavior(GO:0008050) |
1.0 | 1.0 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
1.0 | 2.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.0 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 5.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 1.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.0 | 4.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.0 | 4.8 | GO:0072553 | terminal button organization(GO:0072553) |
1.0 | 1.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.0 | 1.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.9 | 5.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 5.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 2.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 3.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.9 | 0.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.9 | 1.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.9 | 2.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.9 | 3.6 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 3.6 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 3.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 8.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.9 | 3.6 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.9 | 12.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.9 | 2.7 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.9 | 6.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.9 | 2.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.9 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 2.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 11.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.9 | 2.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.9 | 4.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.9 | 7.0 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.9 | 5.3 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.9 | 2.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.9 | 2.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.9 | 2.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 3.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.9 | 2.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 2.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.9 | 1.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.9 | 2.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.9 | 0.9 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.9 | 0.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.9 | 5.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 0.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.8 | 0.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.8 | 0.8 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.8 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 4.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.8 | 2.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.8 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 7.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 2.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.8 | 0.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.8 | 1.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.8 | 1.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 3.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.8 | 2.4 | GO:0006901 | vesicle coating(GO:0006901) |
0.8 | 1.6 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.8 | 2.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.8 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 19.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.8 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 2.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 1.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.8 | 3.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 0.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.8 | 2.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 3.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 1.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.8 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.7 | 1.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.7 | 2.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 0.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.7 | 2.2 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 2.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 0.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.7 | 5.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 2.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 7.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 3.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 8.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.7 | 2.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 4.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 4.2 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 1.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.7 | 2.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.7 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 2.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 9.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.7 | 4.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.7 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 6.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.7 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 6.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.7 | 6.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 2.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.7 | 0.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 1.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.7 | 6.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.7 | 10.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 1.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.7 | 2.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 2.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 8.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 6.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 1.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.7 | 1.3 | GO:0003097 | renal water transport(GO:0003097) |
0.7 | 2.7 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.7 | 0.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 2.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 2.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 1.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 2.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 0.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.7 | 1.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 4.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.7 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 3.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.7 | 2.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 4.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 7.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 3.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.6 | 3.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.6 | 5.1 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 1.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 1.3 | GO:0033622 | integrin activation(GO:0033622) |
0.6 | 0.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 1.3 | GO:1901563 | response to camptothecin(GO:1901563) |
0.6 | 3.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 1.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 1.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 1.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 6.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 2.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 1.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 12.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 1.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.6 | 6.1 | GO:0060068 | vagina development(GO:0060068) |
0.6 | 4.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 10.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 2.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 8.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.6 | 1.8 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 1.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.6 | 1.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 6.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 1.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 1.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 1.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 2.9 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.6 | 2.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.6 | 0.6 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.6 | 1.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 1.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.6 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 5.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 1.7 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.6 | 4.0 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 1.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 0.6 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.6 | 2.9 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.6 | 3.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 0.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.6 | 1.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 3.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 1.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.6 | 4.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 2.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 2.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 1.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 2.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.6 | 1.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.6 | 1.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 2.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 1.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 6.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 4.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.5 | 2.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 1.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 0.5 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.5 | 1.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 1.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 3.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 1.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 1.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 3.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.5 | 1.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 0.5 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.5 | 2.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 5.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 6.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 1.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 1.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.5 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 3.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 1.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 3.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 4.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 2.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 2.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 1.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.5 | 4.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.5 | 3.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 0.5 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.5 | 3.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.5 | 2.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.5 | 5.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 4.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.6 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.5 | 1.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 3.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 3.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.5 | 2.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 2.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.5 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 1.0 | GO:1902946 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.5 | 0.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.5 | 1.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 6.6 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 3.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 3.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 1.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.5 | 2.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 1.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.5 | 2.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 2.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 2.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 | 2.5 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.5 | 3.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 5.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 2.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.5 | 1.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.5 | 3.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 7.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 4.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 2.0 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 4.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 0.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 3.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.5 | 3.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 1.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.5 | 1.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 1.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 4.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 2.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 1.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 10.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.5 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.5 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.4 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 0.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.5 | 1.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 1.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 0.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 2.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 4.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.5 | 9.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 2.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 4.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 2.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 0.5 | GO:0051645 | Golgi localization(GO:0051645) |
0.5 | 1.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 3.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.5 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 1.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.5 | 1.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 3.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.5 | 2.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 2.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 0.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 0.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.4 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 0.4 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 2.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 0.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 6.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 0.4 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.4 | 1.8 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 1.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 11.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 0.4 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.4 | 1.3 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.3 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.4 | 1.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 0.9 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.4 | 0.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 3.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.4 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.4 | 0.9 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.4 | 3.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 0.9 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.7 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 4.6 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.4 | 0.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 1.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 0.8 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.4 | 0.4 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.4 | 0.4 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 0.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 4.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.4 | 1.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 0.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.4 | 2.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 3.7 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.4 | 6.5 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.4 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 1.6 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 0.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 0.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.4 | 0.8 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 0.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 4.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.4 | 2.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 1.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 2.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.4 | 2.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.4 | 0.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 1.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 2.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 0.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.2 | GO:0070293 | renal absorption(GO:0070293) |
0.4 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 1.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 5.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 1.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.4 | 0.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 3.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 5.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.4 | 1.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 1.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 0.8 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.4 | 1.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 8.5 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.4 | 2.7 | GO:0007379 | segment specification(GO:0007379) |
0.4 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 3.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 3.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 3.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.8 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.4 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 2.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.4 | 0.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 0.7 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 4.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 2.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 3.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.8 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.4 | 8.5 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 1.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 2.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.4 | 0.7 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.4 | 3.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 0.7 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.4 | 2.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 1.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 1.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 3.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.1 | GO:0015819 | lysine transport(GO:0015819) |
0.4 | 7.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 1.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.4 | 2.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 3.5 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.4 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 1.8 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.4 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 2.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 2.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 0.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.4 | 12.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 1.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 1.4 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.4 | 0.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 1.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 2.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 2.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 1.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 0.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) regulation of ceramide biosynthetic process(GO:2000303) |
0.3 | 1.4 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 5.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.0 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 0.3 | GO:0098751 | bone cell development(GO:0098751) |
0.3 | 1.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 3.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 2.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.3 | 10.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.3 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 8.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 1.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 3.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 3.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 2.0 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 2.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 2.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.3 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 4.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 1.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 0.3 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 1.0 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.3 | 1.6 | GO:0042148 | strand invasion(GO:0042148) |
0.3 | 0.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 1.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.6 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.3 | 4.7 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.3 | 0.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.3 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 3.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 7.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.6 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.3 | 0.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 2.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.3 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 3.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 0.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.9 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 1.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.3 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 2.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 3.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 3.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 3.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.3 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 2.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 1.2 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.3 | 0.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 1.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 0.6 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 5.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.3 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 3.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.3 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 2.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 3.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 1.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 1.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 2.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 2.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.3 | 2.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 2.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.3 | 2.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 1.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.3 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.3 | 0.3 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 5.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 2.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 0.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0060157 | urea transport(GO:0015840) urinary bladder development(GO:0060157) |
0.3 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 2.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 3.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 1.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 2.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 2.6 | GO:0032438 | melanosome organization(GO:0032438) |
0.3 | 0.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 1.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.3 | 0.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.3 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.5 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 2.3 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 1.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 1.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 7.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 2.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 3.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 2.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.7 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 1.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.2 | 0.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.9 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.5 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.2 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 2.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.9 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 1.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 2.0 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.1 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 3.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.9 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 1.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 1.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 2.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.8 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.2 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.6 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 1.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 1.9 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.0 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.4 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.6 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 4.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 0.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.4 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.8 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.6 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 1.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 2.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.2 | GO:1990182 | exosomal secretion(GO:1990182) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.4 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.4 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.2 | 0.8 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.4 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 2.8 | GO:0035904 | aorta development(GO:0035904) |
0.2 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.2 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.9 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.2 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 8.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 3.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 1.6 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.2 | 0.5 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.2 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.9 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 3.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.3 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 1.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.2 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 1.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 2.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) |
0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.2 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 1.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.2 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 3.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 1.1 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.6 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 3.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 1.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 1.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 2.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 2.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 1.0 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 1.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 3.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 1.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 2.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 1.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.3 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.8 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.2 | GO:0098534 | centriole assembly(GO:0098534) |
0.1 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.8 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 1.2 | GO:0032392 | DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 0.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 3.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.4 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.3 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.4 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.9 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.7 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 4.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.1 | 2.5 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 3.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) prostaglandin secretion(GO:0032310) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 1.7 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.6 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.7 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.1 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.3 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 1.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.7 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.1 | 3.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 1.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 2.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.6 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 1.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 1.8 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 2.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.1 | 0.6 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 3.7 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.2 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.8 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 2.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 8.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.7 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 1.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.8 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.1 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.1 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.5 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.1 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 1.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.2 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 2.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.8 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.0 | 0.7 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.0 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0000393 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.0 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 2.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.0 | 0.5 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 1.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 1.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.6 | GO:0060323 | head morphogenesis(GO:0060323) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 2.3 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 1.1 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.0 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 20.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.0 | 8.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.8 | 5.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.6 | 4.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.4 | 6.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.3 | 4.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 3.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.2 | 3.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.2 | 3.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.2 | 6.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.2 | 7.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.2 | 3.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.2 | 3.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 4.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.1 | 3.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 6.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 1.0 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
1.0 | 3.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 4.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.0 | 3.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.0 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.0 | 3.9 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 3.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 4.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.9 | 12.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 7.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 5.3 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 9.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 3.3 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 4.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 1.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 2.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.8 | 2.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 6.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 3.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.8 | 2.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 5.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 4.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 3.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 2.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 4.4 | GO:0005818 | aster(GO:0005818) |
0.7 | 2.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 2.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 15.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 2.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 4.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 2.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.6 | 7.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 6.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.6 | 3.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 3.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 1.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 1.9 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.6 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 1.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.6 | 2.5 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 1.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 11.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 1.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 1.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 6.1 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.5 | 2.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 2.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 4.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 2.1 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 4.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 2.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 3.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 3.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 2.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 4.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 2.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 5.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 3.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 8.7 | GO:0043034 | costamere(GO:0043034) |
0.5 | 2.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 4.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 1.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 1.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 1.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 3.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 6.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 3.8 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 5.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.5 | 0.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.5 | 5.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 5.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 14.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 7.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.4 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 18.5 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 3.5 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 30.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 2.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 0.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 6.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 4.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.4 | 4.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 3.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 6.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 2.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 22.8 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 1.5 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 3.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 1.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 13.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 13.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 5.0 | GO:0031672 | A band(GO:0031672) |
0.4 | 2.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 21.5 | GO:0016605 | PML body(GO:0016605) |
0.4 | 5.6 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 2.1 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 2.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 2.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 2.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 7.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 1.0 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 3.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 4.0 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 5.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 2.3 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 4.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 32.9 | GO:0005903 | brush border(GO:0005903) |
0.3 | 3.5 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 2.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 2.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 2.9 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 10.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 7.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 3.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 2.2 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 7.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 2.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 0.9 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 1.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 2.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 4.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 3.0 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 3.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.2 | GO:0031430 | M band(GO:0031430) |
0.3 | 2.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 6.1 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 2.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 3.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 11.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 22.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 5.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 1.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 2.7 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 2.1 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 4.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 2.3 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 1.0 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 6.3 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 2.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 6.2 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 8.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 5.8 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.4 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 2.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 3.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 1.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 14.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 2.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 4.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 3.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 2.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 4.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.4 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 3.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 9.1 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 4.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 6.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.9 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 13.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.8 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 6.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 4.0 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) DNA-directed RNA polymerase II, holoenzyme(GO:0016591) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.2 | 10.6 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 5.4 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 9.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 22.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 21.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 3.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 10.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.2 | 6.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 2.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 171.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 5.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 4.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 4.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 36.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 9.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 6.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 14.2 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 11.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 3.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 19.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 73.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 4.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 1.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 7.0 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 15.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.4 | 10.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.0 | 9.0 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.3 | 9.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.9 | 5.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.9 | 5.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.9 | 7.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.9 | 9.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 5.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.7 | 5.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.7 | 11.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.7 | 5.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.7 | 5.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.6 | 4.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 12.9 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.6 | 12.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.6 | 4.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 4.7 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 6.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.5 | 6.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.4 | 4.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 4.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.4 | 11.3 | GO:0008430 | selenium binding(GO:0008430) |
1.4 | 1.4 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.3 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.3 | 5.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 3.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.3 | 3.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.2 | 4.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 3.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.2 | 3.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.2 | 3.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.2 | 3.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.2 | 1.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.2 | 3.5 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.1 | 6.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.1 | 4.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.1 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 6.7 | GO:0038132 | neuregulin binding(GO:0038132) |
1.1 | 6.6 | GO:0008199 | ferric iron binding(GO:0008199) |
1.1 | 2.2 | GO:0030519 | snoRNP binding(GO:0030519) |
1.1 | 7.6 | GO:0046790 | virion binding(GO:0046790) |
1.1 | 3.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.1 | 5.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 5.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 3.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 3.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.0 | 4.1 | GO:0045340 | mercury ion binding(GO:0045340) |
1.0 | 3.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.0 | 4.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.0 | 6.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.0 | 3.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 2.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 4.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 2.8 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.9 | 2.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.9 | 2.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 2.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.9 | 3.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 0.9 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.9 | 14.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 2.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 8.0 | GO:0046977 | TAP binding(GO:0046977) |
0.9 | 2.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 2.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 3.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.9 | 2.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 16.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.8 | 4.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.8 | 4.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 1.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 10.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.8 | 2.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.8 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 2.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 0.8 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.8 | 3.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.8 | 4.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 2.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 4.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 2.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.8 | 4.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 1.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.8 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 3.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.8 | 3.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.8 | 1.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.8 | 1.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.8 | 4.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 3.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.7 | 2.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 2.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.7 | 2.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 0.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.7 | 2.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 2.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.7 | 2.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 3.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 4.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 7.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 2.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 2.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.7 | 2.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 3.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 9.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 3.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 3.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 2.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 2.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 4.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 2.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 2.0 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 2.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.7 | 5.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.7 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 3.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 1.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 1.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 2.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 2.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.6 | 1.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 5.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.6 | 5.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 5.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 1.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.6 | 1.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 2.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.6 | 6.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 5.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 1.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 2.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 5.5 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 6.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 3.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 3.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 3.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.6 | 4.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 4.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.6 | 3.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 1.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.6 | 2.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 2.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.6 | 8.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.6 | 1.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 2.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 1.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.6 | 1.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.6 | 1.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 6.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 3.9 | GO:0019825 | oxygen binding(GO:0019825) |
0.6 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 1.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.6 | 11.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 2.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 7.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 3.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 7.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 2.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 2.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.5 | 4.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 2.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 7.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 2.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 2.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 1.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 2.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 1.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 1.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 1.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 4.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 3.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 6.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 5.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 3.0 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 4.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 1.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 1.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.5 | 8.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 14.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 9.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 3.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 5.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 2.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 7.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 6.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 5.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 3.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 4.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 2.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 2.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 3.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 0.9 | GO:0060229 | lipase activator activity(GO:0060229) |
0.5 | 0.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 8.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 4.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 2.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 3.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 1.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 2.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 3.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 3.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 2.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 4.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 6.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 17.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 2.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 8.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 5.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 9.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 4.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 2.4 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 11.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 3.2 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.4 | 1.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 3.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 3.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 2.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 11.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 11.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 0.8 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.4 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 2.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 2.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 0.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.4 | 0.4 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.4 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 2.6 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.4 | 1.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 5.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 2.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 4.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 2.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.4 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 3.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 3.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 7.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.4 | 1.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.4 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 1.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 2.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 1.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.0 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 4.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.3 | 2.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 4.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 3.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 2.0 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 3.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 3.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 2.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 1.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 0.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 2.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 1.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 6.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 6.0 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 1.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 1.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 2.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 4.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 4.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 1.1 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 4.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 4.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 3.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 3.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 24.7 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 6.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 3.7 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
0.3 | 2.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 0.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 1.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 2.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 2.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 0.3 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.2 | 7.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 3.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 6.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 3.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.9 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 9.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 3.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 4.3 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 33.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 3.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 6.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 5.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 1.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.0 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 6.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 7.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 6.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 2.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 4.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 7.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 12.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.9 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 1.3 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.2 | 2.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 4.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.5 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.2 | 1.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 1.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 5.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 4.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 27.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 16.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 7.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 2.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 4.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 3.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.7 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 9.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 4.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 3.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.1 | 8.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 12.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 5.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 6.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 1.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 3.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 2.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 16.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 5.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 9.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 5.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 4.7 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 5.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 2.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 12.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.8 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) sugar transmembrane transporter activity(GO:0051119) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 3.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 1.6 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.6 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.0 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 16.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.3 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 3.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 23.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.9 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 9.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 25.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 9.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.8 | 5.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 2.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 4.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 1.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.7 | 2.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 22.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 29.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 10.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 17.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.6 | 22.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 4.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 1.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 16.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 11.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 6.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 7.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 4.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 4.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 14.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 1.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 20.9 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 24.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 4.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 10.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 2.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 4.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 9.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 2.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 16.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 8.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 7.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 15.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 13.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 3.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 7.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 2.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 11.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 6.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 7.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 8.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 6.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 3.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 7.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 6.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 6.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 5.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 21.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 7.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 3.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 5.9 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 6.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 3.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 7.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 3.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 5.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 3.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 3.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 8.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 8.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 14.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 8.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.9 | 9.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 8.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 13.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.8 | 30.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.8 | 12.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 8.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 2.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.8 | 17.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.7 | 6.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 11.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 7.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 4.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 7.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 9.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 15.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 20.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.7 | 6.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 2.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.7 | 6.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.7 | 7.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 7.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 11.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 4.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 8.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.6 | 5.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 1.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.5 | 4.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 7.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 6.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 3.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 11.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 8.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 4.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.5 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 19.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 8.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 4.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 12.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 9.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.5 | 5.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 6.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 3.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.5 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 4.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 1.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 5.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 6.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.4 | 3.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 11.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 13.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 3.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 4.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 9.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 4.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.4 | 2.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 5.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 7.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 10.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 11.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 5.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 5.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 11.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 2.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 6.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 1.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 7.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 4.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 3.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 7.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 26.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 2.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 13.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 2.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 3.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 1.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 6.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 3.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 3.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.3 | 5.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 4.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 3.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 4.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 6.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 4.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 5.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 6.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 2.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 35.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 1.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 5.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 6.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 4.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 8.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 18.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 4.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 1.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 2.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 4.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 9.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 7.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 10.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 3.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 8.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 4.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 6.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 4.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 3.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 9.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 10.9 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 2.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |